ScholarIQanswers from OpenAlex

NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro

PaperCitations, authors & open-access status

NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro is a paper indexed in ScholarIQ from OpenAlex.

How many citations does NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro have?

ScholarIQcitation count

NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro has 48 citations in the OpenAlex counts ScholarIQ stores.

When was NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro published?

ScholarIQyear

NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro has 2014 year in the ScholarIQ index.

What is the open-access status of NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro?

ScholarIQoa status

NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro has closed oa status in the ScholarIQ index.

What is the DOI of NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro?

ScholarIQdoi

The DOI for NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro is on the source record.

What is the PMID of NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro?

ScholarIQpmid

The PMID for NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro is on the source record.

What is the OpenAlex record for NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro?

ScholarIQopenalex

The OpenAlex for NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial